Haleon, Pfizer and Sensodyne
Drug giant Pfizer sells $3.3 billion stake in Sensodyne-maker Haleon
Pfizer sold a stake in British consumer healthcare group Haleon worth about $3.26 billion on Monday, cutting its shareholding in the maker of Sensodyne toothpaste and Panadol and Advil painkillers to 15% from 22.
Pfizer sells further shares in Sensodyne maker Haleon for £2.4bn
Pfizer sells further shares in Sensodyne maker Haleon for £2.4bn - Haleon was formed in 2019 by the merger of the consumer healthcare businesses of GSK and US rival Pfizer, but was spun out and floated in 2022.
Pfizer sells stake in Sensodyne and Panadol maker Haleon worth around £2.4bn
Pfizer sold 640 million shares in Haleon for 380p each, reducing its holding in the consumer healthcare firm by 7.6%
Pfizer to offload about 6% stake in Sensodyne-maker Haleon, says bookrunner
Haleon separately said on Monday it had agreed to make an off-market purchase of about 230 million pounds ($308.18 million) worth of ordinary shares from Pfizer. In March, the U.S. pharma major had sold about $3.
Pfizer Offloads $3.3 Billion Stake in Sensodyne-Maker Haleon
(Reuters) - Pfizer offloaded shares worth roughly $3.26 billion in Haleon at 380 pence apiece, cutting its stake to 15% in the world's largest standalone consumer healthcare firm, a bookrunner said on Tuesday.
Pfizer sells $3.3 billion stake in Sensodyne-maker Haleon
Pfizer has sold a stake in British consumer healthcare group Haleon worth about $3.26 billion, cutting its shareholding in the maker of Sensodyne toothpaste and Panadol and Advil painkillers to 15% from 22.
Drug giant Pfizer sells $3.3 bln stake in Sensodyne-maker Haleon
Pfizer sold a stake in British consumer healthcare group Haleon worth about $3.26 billion on Monday, cutting its shareholding in the maker of Sensodyne toothpaste and Panadol and Advil painkillers to 15% from 22.
Haleon To Buy Addl. 33% Stake In China JV, Totaling 88%
Haleon Plc (HLN, HLN.L), a British consumer healthcare company, announced Friday that it has entered into an agreement to acquire an
Haleon to Increase Stake in China JV to 88%
Dow Jones Newswires is a market-moving financial and business news source, used by wealth managers, institutional investors and fintech platforms around the world to identify trading and investing opportunities, strengthen advisor-client relationships and build investor experiences. Learn More. Back To Top
Sensodyne maker Haleon to raise stake in China JV
(Reuters) -British consumer healthcare company Haleon said on Friday it has agreed to increase its stake in its Chinese joint venture to 88% from 55% for 4.47 billion yuan ($637.35 million). The joint venture,
Harper's Bazaar6d
The 10 Best Whitening Toothpastes That Dentists Love
It’s been said that you’re never fully dressed without a smile, and just like the outfits we keep in rotation, it’s as important to help your teeth look their best. Following a consistent ...
usaherald7d
Pfizer Sells Shares in Haleon, Raising £2.43B in Share Sale
Pharmaceutical giant Pfizer Inc. announced on Tuesday that it has reduced its stake in British consumer healthcare company ...